Clinical Trial Update: A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function [Phase 1]

View source ↗

Summary

Phase 1 study comparing plasma levels of GSK189075 after a single dose in subjects with normal versus reduced kidney function, conducted in the context of Type …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• GSK189075 (GSK189075)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Type 2 Diabetes Mellitus, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED